Norway Real World Evidence Solutions Market Size & Outlook
Norway real world evidence solutions market, 2018-2030 (US$M)
Related Markets
Norway real world evidence solutions market highlights
- The Norway real world evidence solutions market generated a revenue of USD 25.5 million in 2023 and is expected to reach USD 42.5 million by 2030.
- The Norway market is expected to grow at a CAGR of 7.6% from 2024 to 2030.
- In terms of segment, services was the largest revenue generating component in 2023.
- Services is the most lucrative component segment registering the fastest growth during the forecast period.
Real world evidence solutions market data book summary
| Market revenue in 2023 | USD 25.5 million |
| Market revenue in 2030 | USD 42.5 million |
| Growth rate | 7.6% (CAGR from 2023 to 2030) |
| Largest segment | Services |
| Fastest growing segment | Services |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Services, Data Sets |
| Key market players worldwide | IQVIA Holdings Inc, International Business Machines Corp, Thermo Fisher Scientific Inc, PAREXEL, PerkinElmer, Icon PLC, Oracle Corp, Syneos Health, Medpace Holdings Inc |
Other key industry trends
- In terms of revenue, Norway accounted for 1.0% of the global real world evidence solutions market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany real world evidence solutions market is projected to lead the regional market in terms of revenue in 2030.
- Germany is the fastest growing regional market in Europe and is projected to reach USD 352.8 million by 2030.
Services was the largest segment with a revenue share of 57.65% in 2023. Horizon Databook has segmented the Norway real world evidence solutions market based on services, data sets covering the revenue growth of each sub-segment from 2018 to 2030.
The RWD refers to data collected from various sources related to patient health status and the delivery of healthcare services. RWE is the clinical evidence obtained from the analysis of RWD, providing insights about usage, benefits, and risks of medical products.
In Norway, the RWE market is expected to experience significant growth, primarily due to the increasing emphasis on integrated evidence planning, which expanded the integration of RWE in evidence-generation plans for medical assets.
Norway is increasingly interested in utilizing real-world evidence (RWE) alongside traditional randomized clinical trials (RCTs) to inform decision-making in healthcare. In recent years, the Norwegian Medicines Agency has been working to develop guidelines for using RWE in drug development and approval processes.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Real World Evidence Solutions Market Scope
Real World Evidence Solutions Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Norway real world evidence solutions market size, by component, 2018-2030 (US$M)
Norway Real World Evidence Solutions Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
